Contribution of UGT1A1 genetic polymorphisms related to axitinib pharmacokinetics to safety and efficacy in patients with renal cell carcinoma

Overview of attention for article published in Medical Oncology, March 2018

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Above-average Attention Score compared to outputs of the same age and source (59th percentile)

Mentioned by

twitter: 3 X users

Citations

dimensions_citation: 18 Dimensions

Readers on

mendeley: 31 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 3 X posts from 3 X users, with an upper bound of 3,829 followers.

RT @GrupoPKgen_SEFH: #Axatinib Contribution of UGT1A1 genetic #polymorphisms related to #pharmacokinetics to safety and efficacy in patient…

Reply Repost Favourite

RT @GrupoPKgen_SEFH: #Axatinib Contribution of UGT1A1 genetic #polymorphisms related to #pharmacokinetics to safety and efficacy in patient…

Reply Repost Favourite

#Axatinib Contribution of UGT1A1 genetic #polymorphisms related to #pharmacokinetics to safety and efficacy in patients with renal cell carcinoma https://t.co/jLra8MEtL9

Reply Repost Favourite